TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T15556	Endothelial plasminogen activator inhibitor	B2Q9EX	N,N''-(Ethane-1,2-diyl)bis(N-ethylbenzenesulfonamide)	Investigative	46231365	C18H24N2O4S2	396.5	CCN(CCN(CC)S(=O)(=O)C1=CC=CC=C1)S(=O)(=O)C2=CC=CC=C2	IC50 > 300000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	B60LIH	US9120744, Cde-069	Investigative	59350365	C20H22O10	422.4	COC1=CC(=CC(=C1O)OC)C(=O)OCCOC(=O)C2=CC(=C(C(=C2)OC)O)OC	IC50 = 562000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	B8TPJ1	Euglobal IIC	Investigative	11728770	C23H30O5	386.5	CC(C)CC(=O)C1=C(C(=C2C(=C1O)C[C@H]3C[C@@H](C=C[C@]3(O2)C)C(C)C)C=O)O	IC50 = 700000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	B9GF1J	US9120744, Cde-065	Investigative	59350354	C22H26N2O8	446.4	COC1=CC(=CC(=C1O)OC)C(=O)N2CCN(CC2)C(=O)C3=CC(=C(C(=C3)OC)O)OC	IC50 = 423000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BEY21X	N,N''-Bis(3,4-dihydroxybenzenesulfonyl)piperazine	Investigative	46232295	C16H18N2O8S2	430.5	C1CN(CCN1S(=O)(=O)C2=CC(=C(C=C2)O)O)S(=O)(=O)C3=CC(=C(C=C3)O)O	IC50 > 300000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BFYI87	N,N''-(Ethane-1,2-diyl)bis(N-ethyl-3,4-dimethoxybenzenesulfonamide)	Investigative	46232215	C22H32N2O8S2	516.6	CCN(CCN(CC)S(=O)(=O)C1=CC(=C(C=C1)OC)OC)S(=O)(=O)C2=CC(=C(C=C2)OC)OC	IC50 > 300000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BHZ0P8	US9120744, Cde-011	Investigative	25114112	C22H26O13	498.4	C1=C(C=C(C(=C1O)O)O)C(=O)OCCOCCOCCOCCOC(=O)C2=CC(=C(C(=C2)O)O)O	IC50 = 338000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BJ5U0K	N,N''-(Ethane-1,2-diyl)bis(N-ethyl-2,5-dihydroxybenzenesulfonamide)	Investigative	46231364	C18H24N2O8S2	460.5	CCN(CCN(CC)S(=O)(=O)C1=C(C=CC(=C1)O)O)S(=O)(=O)C2=C(C=CC(=C2)O)O	IC50 > 300000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BJD6R0	N,N''-(Ethane-1,2-diyl)bis(N-ethyl-4-hydroxybenzenesulfonamide)	Investigative	46231363	C18H24N2O6S2	428.5	CCN(CCN(CC)S(=O)(=O)C1=CC=C(C=C1)O)S(=O)(=O)C2=CC=C(C=C2)O	IC50 > 300000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BJKX10	N,N'-Trimethylenebis(3,4,5-trihydroxybenzamide)	Investigative	10091045	C17H18N2O8	378.3	C1=C(C=C(C(=C1O)O)O)C(=O)NCCCNC(=O)C2=CC(=C(C(=C2)O)O)O	IC50 = 269000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BK4X0I	N,N''-(Butane-1,4-diyl)bis(3,4-dihydroxybenzenesulfonamide)	Investigative	46232293	C16H20N2O8S2	432.5	C1=CC(=C(C=C1S(=O)(=O)NCCCCNS(=O)(=O)C2=CC(=C(C=C2)O)O)O)O	IC50 > 3000000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BLF80M	N,N''-(Ethane-1,2-diyl)bis(3,4-dihydroxybenzenesulfonamide)	Investigative	25114330	C14H16N2O8S2	404.4	C1=CC(=C(C=C1S(=O)(=O)NCCNS(=O)(=O)C2=CC(=C(C=C2)O)O)O)O	IC50 = 450000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BNC5J1	US9120744, Cde-033	Investigative	59350314	C25H30N4O11	562.5	CCOC(=O)[C@H](CC1=CC(=C(C=C1)O)[N+](=O)[O-])NC(=O)[C@H](CC2=CC(=C(C=C2)O)[N+](=O)[O-])NC(=O)OC(C)(C)C	IC50 = 246000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BPB5S2	US9120744, Cde-060	Investigative	59350275	C16H14N4O8	390.3	C1=CC(=C(C=C1C(=O)NCCNC(=O)C2=CC(=C(C=C2)O)[N+](=O)[O-])[N+](=O)[O-])O	IC50 = 236000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BR15FE	N,N''-(Hexane-1,6-diyl)bis(3,4-dihydroxybenzenesulfonamide)	Investigative	46232294	C18H24N2O8S2	460.5	C1=CC(=C(C=C1S(=O)(=O)NCCCCCCNS(=O)(=O)C2=CC(=C(C=C2)O)O)O)O	IC50 = 1384000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BR71TC	N,N'-Ethylenebis(3,4,5-trihydroxybenzamide)	Investigative	10498973	C16H16N2O8	364.31	C1=C(C=C(C(=C1O)O)O)C(=O)NCCNC(=O)C2=CC(=C(C(=C2)O)O)O	IC50 = 900000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BRH4S0	US9120744, Cde-064	Investigative	59350316	C22H28N2O8	448.5	CN(CCN(C)C(=O)C1=CC(=C(C(=C1)OC)O)OC)C(=O)C2=CC(=C(C(=C2)OC)O)OC	IC50 = 2204000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BU76YS	US9120744, Cde-061	Investigative	59350282	C20H20O10	420.4	C1CC(CCC1OC(=O)C2=CC(=C(C(=C2)O)O)O)OC(=O)C3=CC(=C(C(=C3)O)O)O	IC50 = 332000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BVK26T	N,N''-(Ethane-1,2-diyl)bis(N-ethyl-3-hydroxybenzenesulfonamide)	Investigative	46232296	C18H24N2O6S2	428.5	CCN(CCN(CC)S(=O)(=O)C1=CC=CC(=C1)O)S(=O)(=O)C2=CC=CC(=C2)O	IC50 = 343000 nM	Non binder
T15556	Endothelial plasminogen activator inhibitor	BXE81H	Boc-3-nitro-L-tyrosine	Investigative	25114329	C14H18N2O7	326.3	CC(C)(C)OC(=O)N[C@@H](CC1=CC(=C(C=C1)O)[N+](=O)[O-])C(=O)O	IC50 = 386000 nM	Non binder